About this trial
This randomized controlled trial aims to investigate the effects of adding self-myofascial release applied to the plantar fascia and gastrosoleus muscles to an exercise program on foot function, physical performance, and plantar fascia thickness in individuals with type 2 diabetes. Participants aged 30 to 65 years with controlled type 2 diabetes will be randomly allocated to either an exercise-only group or an exercise plus self-myofascial release group. Both groups will complete an eight-week supervised exercise program three times per week. The intervention group will additionally perform self-myofascial release using a foam roller before exercise sessions. Outcomes will include foot function, balance, functional mobility, gait performance, and plantar fascia thickness assessed by ultrasonography before and after the intervention.
Eligibility criteria
Qualifiers
Individuals aged 30 to 65 years
Diagnosed with type 2 diabetes mellitus for at least 1 year
Controlled type 2 diabetes mellitus
Able to ambulate independently without assistive devices
Disqualifiers
Severe pes planus or pes cavus defined by the Foot Posture Index-6 (FPI-6) (score ≥ +10 or ≤ -5)
History of plantar fasciitis
Plantar fascia ulceration
Peripheral neuropathy
Trial design
Treatments tested in this trial
- Exercise Program
- Self-Myofascial Release
Treatment groups
Sponsors and collaborators
Izmir Katip Celebi University
Lead sponsor
Cigli Regional Training Hospital
Collaborator